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Dengue has emerged as the most important viral 
mosquito-borne disease globally. The current risk of 
dengue outbreaks in Europe appeared with the intro-
duction of the vector  Aedes albopictus  mosquito in 
Mediterranean countries. Considering the increasing 
frequency of dengue epidemics worldwide and the 
movement of viraemic hosts, it is expected that new 
autochthonous cases will occur in the future in Europe. 
Arbovirus surveillance started in Catalonia in 2015 to 
monitor imported cases and detect possible local arbo-
viral transmission. During 2015, 131 patients with a 
recent travel history to endemic countries were tested 
for dengue virus (DENV) and 65 dengue cases were 
detected. Twenty-eight patients with a febrile illness 
were viraemic, as demonstrated by a positive real-time 
RT-PCR test for DENV in serum samples. Entomological 
investigations around the viraemic cases led to the 
detection of DENV in a pool of local Ae. albopictus cap-
tured in the residency of one case. The sequence of 
the DENV envelope gene detected in the mosquito 
pool was identical to that detected in the patient. Our 
results show how entomological surveillance con-
ducted around viraemic travellers can be effective for 
early detection of DENV in mosquitoes and thus might 
help to prevent possible autochthonous transmission.
Introduction
The rapid geographical spread of invasive mosqui-
toes and vector borne diseases (VBD) as well as their 
increasing burden are global concerns [1]. Dengue has 
emerged as the most important viral mosquito-borne 
disease globally. In a study from 2013, Bhatt et al. [2] 
estimated that there were 390 million human dengue 
infections per year worldwide, including 96 million 
with clinical manifestations. Dengue is caused by den-
gue virus (DENV), which has four different serotypes 
(DENV-1 to DENV-4), each of which is further subdi-
vided into distinct genotypes [3].
DENV is transmitted through the bites of 
infected Aedes mosquitoes [3] and is present in tropi-
cal and subtropical regions of the world. The disease 
is endemic in more than 100 countries in south-east 
Asia, the Americas, the western Pacific, Africa and the 
Eastern Mediterranean. Demographic- and anthropo-
genic-driven environmental changes combined with 
globalisation and inefficient public health measures 
are considered the principal driving forces for the 
emergence and global spread of dengue in the past 40 
years [4].
At the beginning of the last century, dengue had disap-
peared from Europe [5]. The disease had been present 
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in Spain at least from 1778 and probably until 1927 
[5] and the last European outbreak had occurred in 
Greece in the years 1927–28. During this epidemic, 
DENV had been transmitted by  Ae. aegypti  and had 
caused 1 million cases with more than 1,000 deaths 
[6]. Following the elimination of Ae. aegypti in the first 
half of the 20th century in Europe [7], the risk of dengue 
mainly re-emerged with the introduction of  Ae. albop-
ictus in certain areas [8]. Nevertheless, it is noteworthy 
that on the island of Madeira Ae. aegypti presence has 
been known since 2005 and autochthonous occurrence 
of dengue was reported there in 2012 [9,10].
Ae. albopictus  is an Asian mosquito species, which 
is a vector of several arboviruses including DENV and 
chikungunya virus (CHIKV). Through the global trade 
of used tyres and other goods, it began to expand 
worldwide in the 1970s [11]. From this period, it started 
to spread to parts of Europe, particularly near the 
Mediterranean Sea [8]. Travellers, who are infected 
with DENV or CHIKV in endemic areas of the world, and 
who return to European areas colonised by Ae. albopic-
tus, increase the risk of introduction of the respective 
diseases, particularly if they are in the viraemic phase. 
Concerns about such a risk arose with chikungunya 
outbreaks in Italy in 2007 [12].
Subsequently, in the late summer of 2010, an autoch-
thonous dengue case was reported in Nice, France. The 
likely index case was described as a man who lived in 
the proximity of the first case, and who had recently 
returned from Martinique where he contracted DENV 
infection [13]. Also in August 2010, a 72 year-old man 
in Germany was diagnosed with DENV infection follow-
ing his return from a holiday in Croatia [14]. Because 
shortly after, another DENV infection was detected 
in the same Croatian village than the one visited by 
the German tourist, an autochthonous DENV circula-
tion was suspected in that area of Croatia, prompt-
ing local investigations. Based on molecular analysis, 
the virus was probably introduced by a person who 
arrived in Croatia from the Indian subcontinent in 2010 
[15]. Further autochthonous occurrences of dengue in 
Europe occurred in France in 2013 [16] and in 2015 [17] 
with probable index cases originating from Guadeloupe 
and French Polynesia respectively.
Considering the increasing frequency of dengue epi-
demics worldwide and the movement of viraemic 
hosts, it is expected that new autochthonous cases 
will continue to occur in the future in Europe where the 
vectors are present.
In Catalonia (north-eastern Spain), Ae. albopictus was 
first detected in 2004, corresponding to what is 
considered the first introduction of this species on 
the Iberian Peninsula and in Spain [18]. Because diag-
nosed imported cases of arboviral diseases increased 
in Catalonia from 2009 to 2013 [19], an epidemiological 
surveillance for DENV, including entomological surveys 
of confirmed cases, started in 2015, joining the efforts 
of different public organisations to carry it out. We 
present the surveillance conducted around viraemic 
travellers to early detect DENV in mosquitoes in order 
to avoid and control potential dengue autochthonous 
outbreaks.
Methods
Epidemiological surveillance
In Spain, DENV is monitored at the national level, in 
addition Catalonia has a regional epidemiological 
DENV surveillance. Following national and regional 
guidelines for arbovirus surveillance, travellers return-
ing from endemic areas with a clinical syndrome com-
patible with an arboviral infection were screened for 
DENV and CHIKV in 2015. The arbovirus surveillance, 
which takes place during the period of  Ae. albop-
ictus  activity, usually lasts from May to November, 
however, depending on the entomological situation in a 
given year, it can be expanded. In this study, travellers 
screened between April and December in Catalonia are 
included. The clinical and laboratory notification of 
cases was submitted to the local public health agency, 
which in turn alerted the mosquito control services.
The regional protocol for surveillance included patients 
with a febrile syndrome of less than 7 days of dura-
tion returning from tropical and subtropical areas. 
Samples were submitted for testing to the Microbiology 
Department at Hospital Clinic of Barcelona (centralised 
laboratory for testing) which reports to the local public 
health agency any positive RT-PCR or IgM test. During 
the first week after the onset of symptoms, serum 
Table 
Primers used in RT-nested PCR assays and sequencing
Type of PCR and primers Sequence Localisationa
RT-PCR
EGENE2-Sb 5’-CTGAAACATGGATGTCATCAGAAGG-3’ 758–782
RRT2 5’-GCYGARGCYARYTTTGARGGRG-3’ 2,534–2,555
Nested
FN2 5‘-ATGGCRGCDATYYTGGCDYAY-3‘ 844–865
RN2 5‘-CGKGARTTCATYCCTATCCATGT-3‘ 2,326–2,348
a The genome positions are given according to each dengue virus serotype prototype Jamaica N-1409 strain (M20558).
b This primer was described by Domingo et al. [43].
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samples were tested for the presence of DENV RNA. In 
addition, after the day 4 post-symptom onset, serum 
samples were also tested for the presence of IgM and 
IgG against DENV.
Molecular diagnosis for DENV was performed using a 
specific real time-RT-PCR [20] that discriminates the 
DENV serotypes. Generic flavivirus RT-PCR [21] fol-
lowed by sequencing and a dengue NS1-IgM-IgG detec-
tion rapid test (SD diagnostics Inc., Seoul, Korea) were 
eventually used when additional diagnostic evidence 
was needed. Antibodies against DENV were detected 
by a commercial ELISA kit (Panbio dengue IgM Capture 
ELISA and dengue IgG Indirect ELISA).
The following case definitions were applied in the 
regional protocol for arbovirus surveillance. A prob-
able dengue case was a patient who had travelled to a 
dengue endemic area and presented with (i) fever and 
at least two of the following symptoms: anorexia, a 
positive Tourniquet test, arthralgia, leukopenia, myal-
gia, nausea, rash, any warning sign such as abdomi-
nal pain, persistent vomiting or mucosal bleeding and/
or (ii) had a positive IgM against DENV. A confirmed 
dengue case was a probable case who has been labo-
ratory confirmed through virus isolation, detection of 
the viral genome by RT-PCR or by seroconversion in a 
second sample collected 2–3 weeks after the first sam-
ple. For investigation of autochthonous cases, patients 
with similar compatible symptoms but with no history 
of travel to tropical and subtropical areas in the last 30 
days were considered.
From September 2015, dengue became a mandatorily 
notifiable disease in Catalonia. The data used in the 
present study were retrieved from the records of the 
centralised laboratory in charge of DENV testing for the 
arbovirus regional surveillance programme.
Entomological surveillance
Entomological inspections were carried out by 
the Agència de Salut Pública de Barcelona (ASPB) in the 
city of Barcelona, by the Servei de Control de Mosquits 
del Consell Comarcal del Baix Llobregat  (SCM) in the 
province of Barcelona, by Servei de Control de Mosquits 
Badia de Roses i Baix Ter  in the Girona province and 
Figure 1
Map of dengue cases (n = 17) around whom mosquito pools (n = 65) were tested for dengue virus, Catalonia, Spain, May–
November 2015
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by  Consorci de Polítiques Ambientals de les Terres de 
l’Ebre (COPATE) in the Tarragona and Lleida provinces.
The entomological inspections were performed in a 
radius of ca 100 m around the home of each diagnosed 
DENV viraemic case. This distance was selected based 
on the flight range of Ae. albopictus [22]. Inspection of 
the home address was conducted only with permission 
of the owner and within 10 days after DENV diagnos-
tic, which was considered the duration of the virae-
mia. When permission was not obtained, mosquitoes 
were sampled in the neighbourhood of the residence 
when possible. Other places such as workplace were 
inspected if these had been reported to be visited by 
the case during the viraemic period.
Entomological monitoring activities were carried out 
during the activity period of  Ae. albopictus  in the 
region, which usually starts in May and tapers off in 
November with activity peaks in July–September, 
in agreement with the  Ae. albopictus  phenology in 
other Mediterranean countries [8]. Adult mosqui-
toes were captured using BG Sentinel traps (Biogents 
GmbH, Regensburg, Germany) during time intervals 
of 24 or 48 hours, as well as entomological aspirators 
(Improved Prokopack Aspirator, Mod. 1419, John W. 
Hock Company, Florida, United States (US) and CDC 
Backpack Aspirator Mod. 2846, BioQuip, California 
(CA), US).
All accessible breeding larval sites were identified and 
treated if possible using a formulation of Bacillus thur-
ingiensis israelensis and Bacillus sphaericus (Vectomax 
FG, Valent Biosciences Corporation, Libertyville, Illinois 
(Ill), US). Dissemination of information on mosquito 
prevention and control was conducted in the neigh-
bourhood of viraemic cases’ residences, including 
instructions on how to eliminate mosquito breeding 
sites. When high densities of adults were found (con-
tinuous presence of biting females during the surveys), 
adulticide treatments were conducted if they were con-
sidered to be effective in terms of mosquito population 
reduction.
The female mosquitoes, captured between June and 
November 2015 in the context of this study, were iden-
tified and pooled into groups of up to 35 individuals 
according to the date and site of collection. The mos-
quito pools were kept in cell culture media (DMEM sup-
plemented with 6% penicillin/streptomycin) and sent 
refrigerated to the laboratory at  Centre de Recerca en 
Sanitat Animal (CReSA) for DENV detection.
Dengue virus detection from mosquitoes
All mosquitoes collected were quickly processed for 
the detection of DENV genome. The mosquito samples 
were homogenised and the viral RNA was extracted 
using NucleoSpin Virus kit according to the manufac-
turer’s instructions (NucleoSpin Virus kit, Macherey-
Nagel, Düren, Germany). The mosquito pools were 
screened for DENV using a real-time TaqMan RT-PCR 
(RRT-qPCR) which allows detecting any DENV serotype 
using primers and a probe previously described [23]. 
Amplification was performed using the AgPath One-
Step ID RTPCR kit (Ambion-Applied Biosystems, Foster 
City, CA, US) following the manufacturer’s instructions 
in Fast7500 equipment (Life Technologies, Austin, 
Texas (TX), US). Positive and negative controls for both 
extraction and amplification were used.
Figure 2
Chronological representation of events leading to dengue virus detection in human and in Aedes albopictus samples, 
Catalonia, Spain, 2015
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Figure 3
Investigation of the origin of a dengue virus serotype 2 detected in Aedes albopictus by phylogenetic analysis of the envelope 
gene sequence, Catalonia, Spain, September 2015
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Strains are denoted by GenBank accession number, place and year of isolation. The green dots indicate the human and mosquito sequences 
obtained in our study, which were respectively submitted to GenBank under the accession numbers MH253297 and MH253296. The scale bar 
indicates substitutions per site.
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The supernatant from the homogenised mosquito pool 
that resulted positive was sent to the National Reference 
Laboratory  Centro Nacional de Microbiología  (Instituto 
de Salud Carlos III, Madrid) for confirmation. The viral 
RNA was extracted using the QIamp Viral RNA Mini kit 
according to manufacturer instructions (Qiagen GmbH, 
Hilden, Germany). Two different RT-PCR assays were 
used for DENV detection: an in house real-time RT-PCR 
and a conventional RT-nested-PCR [24].
In order to identify the DENV serotype, genetic mate-
rial from the positive mosquito pool was partially 
sequenced using the cFD2 and MAMD primers previ-
ously described and specific for a fragment of the non-
structural protein 5 (NS5) gene [25]. The amplification 
product was detected by electrophoresis and purified 
using the QIAquick PCR Purification Kit (Qiagen, Hilden, 
Germany). Sequencing reactions were performed with 
ABI Prism BigDye terminator Cycle Sequencing v.3.1 
Ready Reaction (Life Technologies, Austin, TX, US), 
and analysed using an ABI PRISM model 3730 auto-
mated sequencer (Life Technologies, Austin, TX, US). 
Comparisons with published sequences were per-
formed by searches with the basic local alignment 
search tool (BLAST) programme at the National Center 
for Biotechnology Information (NCBI) against the com-
plete GenBank database (http://www.ncbi.nlm.nih.
gov/BLAST/) to identify the detected agent.
Dengue virus characterisation and phylogenetic 
analysis
For genotyping and phylogenetic analysis, the envelope 
gene (E gene) of both mosquito and human samples 
was amplified using the primers described in  Table 1. 
Amplification was performed using a one-step RT-PCR 
kit (Qiagen GmbH, Hilden, Germany) following the man-
ufacturer’s instructions. A total of 5 µL of viral RNA was 
added to 45 µL RT-PCR mix. The RT-PCR mix contained 
1x OneStep RT-PCR buffer, 400 mM of each dNTP, and 
20 pmol of each primer. RT-PCR reactions were carried 
out using an initial reverse transcription step at 50 °C 
for 30 min followed by a denaturation (94 °C, 15 min) 
and 40 cycles including a denaturation (94 °C, 30 s), 
primer annealing (50 °C, 1 min), and primer extension 
(72 °C, 2.5 min) step. A final incubation was carried 
out at 72 °C for 10 min. A second amplification reac-
tion (nested PCR) was seeded with 1 µL of the initial 
amplification product. Amplification was performed 
using Go Taq PCR kit (Promega, Madison, Wisconsin, 
US) following the manufacturer’s instructions and 20 
pmol of each primer. Nested-PCR reactions were car-
ried out using an initial denaturation (94 °C, 2 min) 
and 40 cycles of denaturation (94 °C, 30 s), primer 
annealing (50 °C, 45 s), and primer extension (72 °C, 
2.5 min). A final incubation was carried out at 72 °C 
for 5 min. A phylogenetic tree was constructed with 
the common amplified E gene fragment (1,398 nt). 
The sequences were aligned by MUSCLE, and evo-
lutionary distances were calculated by Tamura–Nei 
(Tn93 + I) model. Phylogenetic dendrograms were con-
structed using the maximum likelihood method and 
bootstrap analysis (1,000 replicates) by the Molecular 
Evolutionary Genetics Analysis programme (MEGA, 
Version 7).
The sequences of the E gene obtained in the study 
were submitted to GenBank Nt Sequence Database 
under the following accession numbers: MH253296 
and MH253297.
Results
During 2015, 131 patients were screened for DENV 
in Catalonia. Sixty-six patients resulted negative by 
RT-PCR and IgM testing and 65 dengue cases were 
detected between April and December. Of these, most 
cases (n = 23) were detected in July. Twenty-eight of 
these patients were viraemic, as demonstrated by the 
presence of DENV RNA in serum samples (dengue con-
firmed cases). In addition, IgM antibodies against DENV 
were detected in 37 patients, who were classified as 
probable dengue cases. Viraemic cases presented with 
a febrile syndrome and had visited at least one of the 
following countries: Colombia, Costa Rica, Dominican 
Republic, El Salvador, Honduras, Indonesia, Malaysia, 
Myanmar/Burma, Philippines, Sri Lanka, Thailand. For 
the cases with a positive IgM, the clinico-epidemiolog-
ical data were incomplete.
Entomological inspections around the DENV viraemic 
cases were performed in a mean of 12 days after symp-
tom onset (range: 1–18 days) that often started before 
the arrival to the country and subsequent visit to medi-
cal care. During these inspections, female mosquitoes 
could be trapped in relation to 17 of the 28 cases, 
either because mosquitoes were present or because 
access to the mosquito breeding sites was possible 
(Figure 1). Most breeding sites were abandoned objects 
with water, including toys, flowerpots or different kinds 
of scuppers. Six hundred females were obtained from 
65 capture sessions performed by BG traps and ento-
mological aspirations. The number of female Ae. albop-
ictus mosquitoes per pool ranged from one to 35. The 
number of mosquito samples per localisation ranged 
from one to four. 
Of all the mosquitoes collected, only one mosquito 
pool sampled in the Baix Llobregat region, Barcelona 
province, on 10 September 2015, was DENV posi-
tive (Figures 1  and  2). This pool was retrieved from 
the residence of a man in his 50s who had travelled 
to El Salvador. Upon returning from the trip he devel-
oped fever, malaise and arthralgia and sought medical 
attention. On 3 September 2015, serum samples from 
the patient were submitted to the clinical microbiology 
laboratory of the Hospital Clinic of Barcelona through 
the regional surveillance programme for arboviruses 
in Catalonia. As the samples were collected within 3 
days of symptom onset, they were screened for DENV 
and CHIKV using specific real-time RT-PCR techniques. 
DENV serotype 2 was detected with a cycle threshold 
value (Ct) of 16 in serum. On 10 September, an ento-
mological investigation was performed at the patient’s 
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residence, a ground floor house where mosquitoes 
were abundant.
Two female mosquito pools were collected from the 
front patio, with 29 and three mosquitoes in each. The 
first one came from a BG Sentinel trap and the second 
one from aspiration. The mosquito pool with 29  Ae. 
albopictus females was DENV positive by RRT-qPCR with 
a Ct of 23.05. The homogenate of the DENV-positive 
mosquito sample was also confirmed to be positive 
by two different molecular assays at the laboratory of 
Arboviruses and Viral Imported Diseases in the Centro 
Nacional de Microbiología (Instituto de Salud Carlos III, 
Madrid).
The DENV detected in the mosquito sample was char-
acterised as DENV serotype 2, as a fragment of its NS5 
gene sequence showed a high similarity to those of 
several DENV serotype 2 isolates from South America. 
Phylogenetic analysis based on E gene sequences con-
firmed the identity of the DENV sequences detected 
in both mosquitoes and patient. The DENV-2 detected 
was related to other strains of the American/Asia geno-
type circulating in the Americas (Figure 3).
Because a person who lived in the same house as the 
viraemic patient was diagnosed with multiple chemi-
cal hypersensibility syndrome, no chemical treatments 
were conducted in the house’s patio, although they were 
carried out in similar patios from contiguous houses. 
Adults were removed using traps and by aspirations. 
All possible breeding sites were eliminated. Larvicidal 
treatments using a formulation of  Bacillus thuringien-
sis israelensis  and  Bacillus sphaericus  (Vectomax FG, 
Valent Biosciences Corporation, Libertyville, Ill, US) 
in all scuppers on the streets in a radius of 100 m 
around the house of the patient, and adulticide treat-
ments using deltamethrin were performed in contigu-
ous houses’ patio and in an abandoned plot situated 
in the back of the houses. On the days following the 
finding of DENV-positive mosquito pools (16, 18 and 21 
September) a great effort was made to further sample 
mosquitoes in the patient’s home and more Ae. albop-
ictus  (237 females) were collected using BG traps and 
aspirations, from the same location, all them resulting 
negative for DENV. Moreover, no autochthonous 
transmission in humans was reported in this location 
during the rest of the mosquito activity season in 2015.
Discussion
The present study shows how epidemiological arbovi-
rus surveillance, including mosquito collection around 
dengue viraemic cases, can be useful to early detect 
DENV circulation in local  Ae. albopictus  mosquitoes. 
The finding of a high viral load of DENV in mosquitoes 
present at the Baix Llobregat region evidenced that 
the level of viraemia in the infected traveller from El 
Salvador was sufficient to efficiently infect local  Ae. 
albopictus, highlighting the risk of DENV autochtho-
nous transmission in this area.
Ae. albopictus population density, vector competence, 
blood feeding behaviour and vector longevity would 
be determinants for both human-to-mosquito and 
mosquito-to-human transmission of dengue in Europe. 
The risk of dengue importation into Europe is greatest 
in August to October due to a high mosquito activity 
in that period and a number of passengers coming 
from dengue-affected areas, some of whom possibly 
in the viraemic phase [26]. Semenza et al. [26] pointed 
out that Barcelona, where  Ae. albopictus  is present, 
is one of the three large European cities with higher 
risk of dengue transmission. The present study, which 
finds DENV in  Ae. albopictus  from Barcelona province 
provides further evidence to this.
Different DENV strains have been involved in autoch-
thonous transmission in Europe since 2010, and all 
belonged to either serotype 1 or serotype 2 [16,17,27-
29]. DENV serotypes 1 and 2 have been the most preva-
lent DENV serotypes in travellers to Europe during the 
last years [30]. In the present study, the DENV serotype 
2 was characterised as originating from America in 
both mosquito and human sera samples.
Ae. albopictus  can only be unequivocally incriminated 
as a vector of dengue where transmission occurs 
in the absence of  Ae. aegypti  or any other potential 
vector [31]. However, to our knowledge, although  Ae. 
albopictus  has been implicated as a vector of DENV 
in all the recent mainland European autochthonous 
transmissions no DENV detection in local mosquitoes 
has been reported before our finding. Despite 
seemingly favourable conditions, places where  Ae. 
albopictus  predominates over  Ae. aegypti  have never 
experienced a typical explosive dengue epidemic 
with severe cases of the disease [32]. Although  Ae. 
albopictus  is overall more susceptible to DENV mid-
gut infection, rates of virus dissemination from the 
mid-gut to other tissues are significantly lower in  Ae. 
albopictus  than in  Ae. aegypti. Therefore,  Ae. albopic-
tus may play a relatively minor role compared with Ae. 
aegypti  in DENV transmission, and this could also be 
partly due to differences in feeding preferences (i.e. 
feeding on humans and animals vs humans only) and 
reduced vector competence [32]. This statement would 
explain the European autochthonous DENV transmis-
sions in Croatia [27] and France [13,17], as well as those 
recently detected in Spain in 2018 [33], where  Ae. 
albopictus  was the suspected vector. Moreover this 
explanation would also concur with the findings of 
our study, whereby DENV was detected in Ae. albopic-
tus mosquitoes around the imported case in Catalonia, 
but no authochonous cases occurred.
Nevertheless, recent examples of rapid arboviral adap-
tation to alternative mosquito vectors as occurred in 
the chikungunya outbreak in Indian Ocean islands in 
2005 [34] should be taken into account and the pos-
sibility of a DENV evolution to be efficiently transmit-
ted by  Ae. albopictus  not disconsidered. Moreover, as 
already reported for DENV, different vector competence 
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of different mosquito populations from the same mos-
quito species can exist [35,36]. Therefore, vector com-
petence studies for DENV in different European  Ae. 
albopictus  mosquito populations such as those 
reported by Vega-Rua et al. [37], in a mosquito popula-
tion of France, which showed high efficiency to trans-
mit DENV, will be useful to better estimate the risk of 
a DENV autochthonous outbreak in a certain area. In 
fact, a recent study has experimentally shown that 
an  Ae. albopictus  strain from Catalonia could sustain 
DENV-2 replication under a simulated Mediterranean 
temperature regime [38], which would be in agreement 
with our detection of a high viral load in the DENV-
positive mosquito pool in the summer 2015.
Integrated vector management techniques such as 
source reduction, public education, pesticide applica-
tion and biological control, produce the optimal con-
trol strategy [39], but with limited success if there is a 
poor participation of communities and a lack of coor-
dination and synchronised implementation [40]. An 
integrated  Aedes  mosquito control strategy requires 
the coordinated involvement of local authorities, 
private partners, organised society and communities. 
In addition to surveillance of Ae. albopictus, maintain-
ing vigilance for any introduction of  Ae. aegypti spe-
cies is essential, to assess the risk of mosquito borne 
diseases and to prepare for the control of disease out-
breaks [9].
Early arbovirus detection and effective public health 
measures reduce the risk of a wider mosquito-borne 
diseases distribution and increased health impact 
on the public. Moreover, given the unpredictability of 
vector-borne disease outbreaks in terms of time, these 
measures will offer relevant, target-oriented strategies 
to mitigate problems from their beginning [41]. In case 
of a dramatic increase of imported viraemic cases, an 
integrated surveillance could be sustainable if a well-
established entomological surveillance framework in 
coordination with public health authorities was main-
tained in time. The results of the present study point 
out that an early intervention is able to detect mosquito 
infection and to likely reduce the risk of autochthonous 
transmission as previously recommended by Rezza [42] 
for areas with relatively cold and dry winters.
The present study highlights the success of an early 
DENV detection in both human and mosquitoes 
and the effectiveness of an epidemiological surveil-
lance, which combines epidemiology with ecology, 
in interrupting local DENV transmission as described 
by Hubaleck [3]. To sum up, this arbovirus surveil-
lance consisted of different components: (i) routine 
diagnosis of human disease, (ii) epidemiological 
investigation, (iii) monitoring and control of Ae. albop-
ictus  population and (iv) testing mosquito vectors for 
DENV. However, this surveillance had some limitations: 
First, complete clinical and epidemiological data were 
not available for some probable cases and therefore 
we could not confirm whether they fulfilled all criteria 
to be classified as dengue cases. On the other hand, 
the travel history was available for confirmed cases 
and the data on the viraemic patient and associated 
DENV-positive mosquitoes were clear. Second, it is 
possible that asymptomatic dengue cases (imported or 
autochthonous) may remain undetected. Third, in some 
instances performing entomological inspections to test 
mosquitoes for DENV can be difficult due to limited 
access of the of viraemic patients’ residences .
Arbovirus surveillance relies on multidisciplinarity 
activities, which are essential for an early detection 
and prompt implementation of control measures to 
avoid local arbovirus transmission. Moreover, com-
munity engagement is necessary to early detect  Ae. 
albopictus  in areas where it is not yet established 
and control its population. Therefore, public health 
professionals responsible for managing disease 
outbreaks and policymakers working together with 
experts from different fields such as virologists, 
molecular biologists, epidemiologists and 
entomologists and society as a whole could guarantee 
a better mosquito-borne disease surveillance. On the 
other hand, epidemiological surveillances require fluid 
communication within all the surveillance components 
and substantial resources that are not always available.
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